Indiana regulators reject Vectren’s plan to build $780M gas plant
The utility had wanted to build the gas-fired plant to replace aging coal-burning units, but regulators said the plan was too risky and inflexible.
The utility had wanted to build the gas-fired plant to replace aging coal-burning units, but regulators said the plan was too risky and inflexible.
The two sides seem to be digging in as a deadline approaches for them to figure out a way to work together after the end of this year.
Long a leader in diabetes and neuroscience drugs, Eli Lilly and Co. is pushing hard and spending record sums to turbocharge its oncology business, potentially a huge growth area.
Dr. Rainer Fischer is giving up the roles of CEO and chief scientific officer, but will continue as senior executive for innovation and discovery.
Nearly 40 states allow patients to get their eyes tested and glasses prescribed online, but Indiana’s 2016 telemedicine law bans such practice here.
The House voted 53-38 Thursday to strip language that would have prohibited the state from approving new power plants for two years, a move widely seen as delaying construction of renewable energy projects.
Paul Elmer, former owner and CEO of Pharmakon Pharmaceuticals in Noblesville, was convicted in federal court of nine counts of adulterating drugs and one count of conspiracy. He was acquitted of an additional count of obstruction of justice.
The company raised about $50 million and had big plans for its product, Redbox-style vending machines in nursing homes that dispensed medicines for patients.
County officials unveiled a mobile health unit that will visit neighborhoods hit hard by hepatitis C and offer health screenings and clean needles in the latest tactic against the opioid epidemic.
Seeking to reduce delays and endless paperwork, Butler’s College of Pharmacy developed a database to help the Indiana Department of Insurance make sure insurers are covering the right drugs.
The House Utilities Committee advanced legislation this week along party lines that would prohibit state regulators from approving any large new power plants until 2021. Environmentalists and utilities say the move could interrupt the transition from coal to renewable fuels and natural gas.
The CEO who took charge last summer of the Indianapolis company that provides health insurance, food, career help and other services to low-income people acknowledges he has a big job ahead.
The industry is retiring coal-fired plants in favor of cheaper energy sources, including gas, solar and wind.
The Indianapolis-based drugmaker could spend more than a half-billion dollars under a licensing deal with ImmuNext of New Hampshire to identify and commercialize a new antibody for immune diseases.
The Carmel startup said its midstage clinical trials met key objectives, an achievement that will it allow to continue developing a technology that measures blood volume and kidney function.
Paul Elmer, who founded Pharmakon 16 years ago and shut it down three years ago, faces charges of adulterating compounded drugs, conspiracy and obstructing a U.S. FDA investigation.
The Indianapolis-based drugmaker said it price for the popular insulin Humalog—after discounts and rebates—fell 8 percent over the past five years, even as list prices skyrocketed.
A bill advancing through the General Assembly would allow PTs to be regulated by their peers, a move that would remove much of the medical hierarchy from the process.
The utility, with more than 300,000 customers in central Indiana, announced a settlement agreement Tuesday with consumer groups.
The landfill is teaming up with two energy companies to capture methane at the landfill and convert it into renewable energy. The partnership is seeking a tax abatement on the project.